BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6704349)

  • 1. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
    Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
    Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
    Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
    Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
    Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
    Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
    Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hyperprolactinemic amenorrhea with Metergoline.
    Bohnet HG; Kato K; Wolf AS
    Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
    Falsetti L; Scagliola P; Turla R; Voltolini AM
    Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
    Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
    Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of different types of treatment in prolactin adenoma].
    Leal Cerro A; García-Luna PP; Astorga Jiménez R; Acosta Delgado D; Santos Español C; Villamil F
    Med Clin (Barc); 1985 Dec; 85(20):823-6. PubMed ID: 4087967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
    Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
    Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.
    Pontiroli AE; Falsetti L
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with prolactinomas.
    Werder Kv; Fahlbusch R; Landgraf R; Pickardt CR; Rjosk HK; Scriba PC
    J Endocrinol Invest; 1978 Jan; 1(1):47-58. PubMed ID: 755842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.